Seeks moderate capital growth whilst protecting employees’ contributions.
The Fund will primarily invest in Shari’ah compliant money market instruments
Max in single security
Max in money market funds
Max in single group
Max maturity of a single security
Max weighted average maturity
Fund Custodian
Fund administrator
Legal Advisor
Shariah Advisors
Auditor
Fund administrator
Legal Advisor
Shariah Advisors
Shari’ah solutions leveraging on local and global expertise
(subject to appointment*)
*Standard Chartered Bank’s appointment as the Custodian and Fund Administrator is subject to, among other things, its internal policy, regulatory approval, product readiness and execution of the relevant definitive service agreements. No representation is made as to when and/or whether the appointment will be concluded eventually. The information contained herein is for illustrative purpose only and should not be relied upon entirely as it is subject to change.
Daman Investments PSC (“Daman”) is a private joint stock company operating under the regulation, control and supervision of the Securities & Commodities Authority of the UAE (“SCA”). Daman is licensed and authorised by the SCA- License Number-301043 for the conduct of the following financial activities: (i) Portfolios Management (Category 2- Dealing in Investment); (ii) Investment Fund Management. (Category 2- Dealing in Investment); and (iii) Promotion (Category 5- Arranging and Advice).
Daman was registered in the Commercial Register on 14 November 2006 as a Private Joint Stock Company with registration number 1001646. Daman is incorporated in Dubai, UAE and operates as an independent entity licensed. Daman’s issued share capital is AED 268,823,500. Pursuant to SCA guidelines, Daman’s capital adequacy ratio must demonstrate a strong capacity to absorb unforeseen losses by having significant and sufficient capital reserves.
Daman Investments © 2024 All Rights Reserved
Daman Investments is regulated by the
Emirates Securities and Commodities Authority (SCA).
Daman Investments © 2024 All Rights Reserved
Privacy Policy | Cookie Statement
